Multicellular living organisms and unmodified parts thereof and – Method of making a transgenic nonhuman animal
Reexamination Certificate
2001-06-27
2009-12-29
Angell, J. E (Department: 1635)
Multicellular living organisms and unmodified parts thereof and
Method of making a transgenic nonhuman animal
C800S009000
Reexamination Certificate
active
07638679
ABSTRACT:
This invention provides a model for the induction of immunological tolerance to antigens. The tolerance model of the invention can be used for screening candidate drugs effective in modulating tolerance. The invention also provides the use of such tolerance-modulating drugs as agents for the treatment of chronic illnesses, including chronic viral infections, such as HCV.
REFERENCES:
patent: 6582692 (2003-06-01), Podsakoff et al.
patent: WO 97/47358 (1997-12-01), None
Y Shimizu et al., Journal of Immunology, “Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice,” 1998, 161:4520-4529.
Ay Lee et al., Hepatology, “Priming of Hepatitis C Virus-Specific Cytotoxic T Lymphocytes in Mice Following Portal Vein Injection of a Liver-Specific Plasmid DNA,” 2000, 31:1327-1333.
Ma Feitelson et al., Journal of Virology, “A Chronic Carrierlike State is Established in Nude Mice Injected with Cloned Hepatitis B Virus DNA,” Apr. 1988, vol. 62, No. 4, pp. 1408-1415.
M Yanagi et al., Proc. Natl. Acad. Sci. USA, “Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee,” Aug. 1997, vol. 94, pp. 8738-8743.
Nakai et al. (Blood, 1998; vol. 91, pp. 4600-4607).
Caine et al., “Induction of Immunological Tolerance by Porcine Liver Allografts,”Nature223:472-476 (1969).
Cantor & Dumont, “Hepatic Suppression of Sensitization to Antigen Absorbed into the Portal System,”Nature215:744-745 (1967).
Cerny & Chisari, “Pathogenesis of Chronic Hepatitis C: Immunological Features of Hepatic Injury and Viral Persistence,”Hepatology30:595-601 (1999).
Cuison et al., “Schistosome Eggs in the Portal Vein Can Induce Tolerance,”International Journal Parasitology25(8):993-998 (1995).
Ehl et al., “Antigen Persistence and Time of T-Cell Tolerization Determine the Efficacy of Tolerization Protocols for Prevention of Skin Graft Rejection,”Nature Medicine4(9):1015-1019 (1998).
Gorczynski, “Regulation of IFN-γ and IL-10 Synthesis in Vivo, as Well as Continuous Antigen Exposure, is Associated With Tolerance to Murine Skin Allogrtafts,”Cell Immunology160:224-231 (1995).
Kamada et al., “Liver Transplantation in the Rat,”Transplantation35(4):304-311(1983).
Kawamura et al., “Transgenic Expression of Hepatitis C Virus Structural Proteins in the Mouse,”Hepatology25:1014-1021 (1997).
Koike et al., “Expression of Hepatitis C Virus Envelope Proteins in Transgenic Mice,”Journal of General Virology76:3031-3038 (1995).
Millard et al., “Morphological Features of Kidney and Liver Allografts in the Pig,”Transplantation Proc.3:505-508 (1971).
Moriya et al., “Hepatitis C Virus Core Protein Induces Hepatic Steatosis in Transgenic Mice,”Journal of General Virology78:1527-1531 (1997).
Pasquinelli et al., “Hepatitis C Virus Core and E2 Protein Expression in Transgenic Mice,”Hepatology25:719-727 (1997).
Qian et al., “Murine Liver Allograft Transplantation: Tolerance and Donor Cell Chimerism,”Hepatology19:916-924 (1994).
Sriwatanawongsa et al., “The Essential Roles of Parenchymal Tissues and Passenger Leukocytes in the Tolerance Induced by Liver Grafting in Rats,”Nature Med.1:428-432 (1995).
Starzl, “Acquired Tolerance, Allograft “Acceptance,” and Immune Suppression,”Transplant. Proc.30:3845 (1998).
Sugiura et al., “Induction of Donor-Specific T Cell Anergy by Portal Venous Injection of Allogeneic Cells,”Immunobiology197:460-477 (1997).
Triger et al., “Studies on Hepatic Uptake of Antigen 1. Comparison of Inferior Vena Cava and Portal Vein Routes of Immunization,”Immunology25:941-950 (1973).
Wakita et al., “Efficient Cinditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by theCre/loxPSystem,”The Journal of Biological Chemistry273:9001-9006 (1998).
Wang et al., “Induction of Specific Allograft Immunity by Soluble Class I MHC Heavy Chain Protein Produced in a Baculovirus Expression System,”Transplantation61:448-457 (1996).
Schmidt et al., “Adjuvant Effect of IL-12: Conversion of Peptide Antigen Administration from Tolerizing to Immunizing for CD8+ T Cells in Vivo,” The Journal of Immunology, 163(5):2561-2567 (1999).
Lee, et al., “Quantification Of The Number Of Cytotoxic T Cells Specific For An Immunodominant HCV-Specific CTL Epitope Primed by DNA Immunization,”Vaccine18:1962-1968 (2000).
Angell J. E
Gorman Robert J.
Novartis Vaccines and Diagnostics Inc.
Robins Roberta L.
Robins & Pasternak LLP
LandOfFree
Tolerance and chronic hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tolerance and chronic hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tolerance and chronic hepatitis C virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4145450